Creatinine test reduces contrast-based nephropathy

Article

Many elderly patients scheduled for contrast-enhanced CT scans who have no reported risk factors may still be at risk of contrast-induced nephropathy. While measuring the creatinine levels is standard, it may be better to assess creatinine clearance as well, according to researchers at the VA North Texas Health Care System.

Many elderly patients scheduled for contrast-enhanced CT scans who have no reported risk factors may still be at risk of contrast-induced nephropathy. While measuring the creatinine levels is standard, it may be better to assess creatinine clearance as well, according to researchers at the VA North Texas Health Care System.

Dr. Mithilesh Kumar and colleagues retrospectively reviewed the charts of 561 consecutive patients during a six-month period. Thirteen percent had a creatinine clearance of less than 50 mL/min, and 25% had clearance less than 60 mL/min. Of these patients, nearly 19% and 22%, respectively, reported no risk factors.

"With these data, we can show referring physicians that it is not an insignificant number of patients who could be put at risk," coauthor Dr. Andre Duerinckx said at the RSNA meeting.

Duerinckx is now the director of MR, CT, and vascular imaging at Forsyth Radiological Associates in Winston-Salem, NC.

Copyright © 2005 CMP Media LLC. All rights reserved.

2/1/05, Issue # 2702, page 18.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.